Akers Biosciences Posts Drop In H1 Profit

Akers Biosciences

reported a decline in its first-half profit. Akers Biosciences' pretax loss for the period dropped to 1.0 million dollars, from $838,352, in the year-ago period. Its revenue fell to $787,194, from $1.1 million. Akers Biosciences' gross profit margin declined to 50% from 66%, while administrative expenses dropped by 31%.